Logo image of SCNX

SCIENTURE HOLDINGS INC (SCNX) Stock Price, Quote, News and Overview

NASDAQ:SCNX - Nasdaq - US80880X1046 - Common Stock - Currency: USD

0.9211  -0.03 (-2.94%)

Premarket: 0.895 -0.03 (-2.83%)

SCNX Quote, Performance and Key Statistics

SCIENTURE HOLDINGS INC

NASDAQ:SCNX (5/20/2025, 8:00:02 PM)

Premarket: 0.895 -0.03 (-2.83%)

0.9211

-0.03 (-2.94%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap11.53M
Shares12.52M
Float8.24M
Yearly Dividend3.08
Dividend Yield168.35%
PE0.07
Fwd PEN/A
Earnings (Next)06-24 2025-06-24
IPO02-18 2020-02-18


SCNX short term performance overview.The bars show the price performance of SCNX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60 -80

SCNX long term performance overview.The bars show the price performance of SCNX in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of SCNX is 0.9211 USD. In the past month the price increased by 7.39%.

SCIENTURE HOLDINGS INC / SCNX Daily stock chart

SCNX Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 36.43 39.17B
DOCS DOXIMITY INC-CLASS A 37.59 9.94B
WAY WAYSTAR HOLDING CORP 50.19 6.86B
CERT CERTARA INC 23.86 1.89B
SDGR SCHRODINGER INC N/A 1.58B
PHR PHREESIA INC N/A 1.50B
GDRX GOODRX HOLDINGS INC-CLASS A 11.68 1.43B
TDOC TELADOC HEALTH INC N/A 1.29B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 1.08B
EVH EVOLENT HEALTH INC - A 23.08 1.03B
HSTM HEALTHSTREAM INC 45.48 874.68M
CCLDO CARECLOUD INC - CCLD 8 3/4 PERP N/A 840.05M

About SCNX

Company Profile

SCNX logo image Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. The company is headquartered in Lutz, Florida and currently employs 14 full-time employees. The company went IPO on 2020-02-18. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The firm's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.

Company Info

SCIENTURE HOLDINGS INC

2420 Brunello Trace

Lutz FLORIDA US

Employees: 14

SCNX Company Website

SCNX Investor Relations

Phone: 18002610281

SCIENTURE HOLDINGS INC / SCNX FAQ

What is the stock price of SCIENTURE HOLDINGS INC today?

The current stock price of SCNX is 0.9211 USD. The price decreased by -2.94% in the last trading session.


What is the ticker symbol for SCIENTURE HOLDINGS INC stock?

The exchange symbol of SCIENTURE HOLDINGS INC is SCNX and it is listed on the Nasdaq exchange.


On which exchange is SCNX stock listed?

SCNX stock is listed on the Nasdaq exchange.


What is SCIENTURE HOLDINGS INC worth?

SCIENTURE HOLDINGS INC (SCNX) has a market capitalization of 11.53M USD. This makes SCNX a Nano Cap stock.


How many employees does SCIENTURE HOLDINGS INC have?

SCIENTURE HOLDINGS INC (SCNX) currently has 14 employees.


What are the support and resistance levels for SCIENTURE HOLDINGS INC (SCNX) stock?

SCIENTURE HOLDINGS INC (SCNX) has a support level at 0.88 and a resistance level at 1.01. Check the full technical report for a detailed analysis of SCNX support and resistance levels.


Should I buy SCIENTURE HOLDINGS INC (SCNX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SCIENTURE HOLDINGS INC (SCNX) stock pay dividends?

SCIENTURE HOLDINGS INC (SCNX) has a dividend yield of 168.35%. The yearly dividend amount is currently 3.08. Check the full fundamental report for a detailed analysis of SCNX dividend history, reliability and sustainability.


When does SCIENTURE HOLDINGS INC (SCNX) report earnings?

SCIENTURE HOLDINGS INC (SCNX) will report earnings on 2025-06-24.


What is the Price/Earnings (PE) ratio of SCIENTURE HOLDINGS INC (SCNX)?

The PE ratio for SCIENTURE HOLDINGS INC (SCNX) is 0.07. This is based on the reported non-GAAP earnings per share of 12.78 and the current share price of 0.9211 USD. Check the full fundamental report for a full analysis of the valuation metrics for SCNX.


What is the Short Interest ratio of SCIENTURE HOLDINGS INC (SCNX) stock?

The outstanding short interest for SCIENTURE HOLDINGS INC (SCNX) is 1.5% of its float. Check the ownership tab for more information on the SCNX short interest.


SCNX Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to SCNX.


Chartmill TA Rating
Chartmill Setup Rating

SCNX Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to SCNX. SCNX has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SCNX Financial Highlights

Over the last trailing twelve months SCNX reported a non-GAAP Earnings per Share(EPS) of 12.78. The EPS increased by 160.7% compared to the year before.


Industry RankSector Rank
PM (TTM) 6631.89%
ROA 8.65%
ROE 11.47%
Debt/Equity 0.04
Chartmill High Growth Momentum
EPS Q2Q%94.19%
Sales Q2Q%-97.74%
EPS 1Y (TTM)160.7%
Revenue 1Y (TTM)-98.47%

SCNX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to SCNX. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners1.85%
Ins Owners33.22%
Short Float %1.5%
Short Ratio0.04
Analysts
Analysts82.86
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A